Antibody Fc mutants with ablated effector functions
US10894836B2 · kind B2 · utility
6Cited by
9References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 17, 2018 |
| Grant date | Jan 19, 2021 |
| Priority date | — |
| Expiry date | Oct 1, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Antibody and other Fc-containing molecules with variations in the Fc region with reduced binding to Fc gamma receptors and resulting activity and can be used in the treatment of various diseases and disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.